Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3651889
Max Phase: Preclinical
Molecular Formula: C29H30Cl2F6N4O3
Molecular Weight: 667.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3651889
Max Phase: Preclinical
Molecular Formula: C29H30Cl2F6N4O3
Molecular Weight: 667.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N1CCC(C(=O)N2CC(c3ccc(Cl)c(Cl)c3)[C@H](N(C)C(=O)N(C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC1
Standard InChI: InChI=1S/C29H30Cl2F6N4O3/c1-16(42)40-8-6-17(7-9-40)26(43)41-14-22(18-4-5-23(30)24(31)10-18)25(15-41)39(3)27(44)38(2)21-12-19(28(32,33)34)11-20(13-21)29(35,36)37/h4-5,10-13,17,22,25H,6-9,14-15H2,1-3H3/t22?,25-/m1/s1
Standard InChI Key: LIXRIEAGLPGVJF-NRWPOFLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 667.48 | Molecular Weight (Monoisotopic): 666.1599 | AlogP: 6.77 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.17 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.67 | CX LogD: 4.67 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.34 | Np Likeness Score: -1.09 |
1. (2013) Nitrogen-containing heterocyclic compound and use of same, |
Source(1):